Literature DB >> 20449127

Metal-NHC complexes: a survey of anti-cancer properties.

Marie-Laure Teyssot1, Anne-Sophie Jarrousse, Michèle Manin, Aurélien Chevry, Stéphane Roche, Frédéric Norre, Claude Beaudoin, Laurent Morel, Damien Boyer, Rachid Mahiou, Arnaud Gautier.   

Abstract

New weapons to fight cancer are constantly needed. Among chemotherapeutics, anti-cancer metal-drugs have enjoyed a long and successful history since the discovery of the benchmark cisplatin. Advances in metal-drug discovery have motivated chemists to build plethora of complex structures. Among them, a novel area is emerging. This article presents a survey of the metal-N-Heterocyclic Carbenes (Ag(I), Au(I), Pd(II) and Cu(I)-NHCs) as potential anti-cancer agents. Most of the metal-NHCs considered display higher cytotoxicities than the reference metallo-drug cisplatin. Some of them are even selective for particular cell lines. Their mechanisms of action at the cellular level are further discussed, showing that the nature of the metal is of great importance. All these promising results demonstrate that this approach deserves more attention and work.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20449127     DOI: 10.1039/b906308k

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  21 in total

Review 1.  Stable cyclic carbenes and related species beyond diaminocarbenes.

Authors:  Mohand Melaimi; Michèle Soleilhavoup; Guy Bertrand
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-15       Impact factor: 15.336

2.  Synthesis and molecular structure of biologically significant bis(1,3-dimesityl-4,5-naphthoquinoimidazol-2-ylidene)gold(I) complexes with chloride and dichloridoaurate counter-ions.

Authors:  Jayaraman Selvakumar; Meredith H Miles; David A Grossie; Kuppuswamy Arumugam
Journal:  Acta Crystallogr C Struct Chem       Date:  2019-03-26       Impact factor: 1.172

3.  N-heterocyclic carbene gold(I) and silver(I) complexes bearing functional groups for bio-conjugation.

Authors:  Mary E Garner; Weijia Niu; Xigao Chen; Ion Ghiviriga; Khalil A Abboud; Weihong Tan; Adam S Veige
Journal:  Dalton Trans       Date:  2015-01-28       Impact factor: 4.390

4.  Organometallic Palladium Complexes with a Water-Soluble Iminophosphorane Ligand as Potential Anticancer Agents.

Authors:  Monica Carreira; Rubén Calvo-Sanjuán; Mercedes Sanaú; Isabel Marzo; María Contel
Journal:  Organometallics       Date:  2012-07-25       Impact factor: 3.876

5.  Aptamer-mediated selective delivery of a cytotoxic cationic NHC-Au(i) complex to cancer cells.

Authors:  Weijia Niu; I-Ting Teng; Xigao Chen; Weihong Tan; Adam S Veige
Journal:  Dalton Trans       Date:  2017-12-19       Impact factor: 4.390

6.  N-Heterocyclic Carbene-Gold(I) Complexes Conjugated to a Leukemia-Specific DNA Aptamer for Targeted Drug Delivery.

Authors:  Weijia Niu; Xigao Chen; Weihong Tan; Adam S Veige
Journal:  Angew Chem Int Ed Engl       Date:  2016-06-17       Impact factor: 15.336

7.  Cytotoxic, anti-proliferative and apoptotic effects of silver nitrate against H-ras transformed 5RP7.

Authors:  Ayse Kaplan; Gulsen Akalin Ciftci; Hatice Mehtap Kutlu
Journal:  Cytotechnology       Date:  2015-10-26       Impact factor: 2.058

Review 8.  Organometallic anticancer compounds.

Authors:  Gilles Gasser; Ingo Ott; Nils Metzler-Nolte
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

9.  Bis(1,3-dimesitylimidazol-yl)gold(I) 2,4,8,10-tetra-phenyl-1,3,5,7,9,11-hexa-oxa-2,4,8,10-tetra-bora-6-borataspiro-[5.5]undeca-ne.

Authors:  Lennart Möhlmann; Ola F Wendt; Magnus T Johnson
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-05-07

10.  Potential of silver against human colon cancer: (synthesis, characterization and crystal structures of xylyl (Ortho, meta, &Para) linked bis-benzimidazolium salts and Ag(I)-NHC complexes: In vitro anticancer studies).

Authors:  Muhammad Adnan Iqbal; Rosenani A Haque; Siti Fatimah Nasri; Ams Abdul Majid; Mohamed B Khadeer Ahamed; Elham Farsi; Tabinda Fatima
Journal:  Chem Cent J       Date:  2013-02-07       Impact factor: 4.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.